<Suppliers Price>

phacolysin

Names

[ CAS No. ]:
3863-80-7

[ Name ]:
phacolysin

[Synonym ]:
Disodium 5,12-dihydroquinoxalino[2,3-b]phenazine-2,9-disulfonate
phacolysin
MFCD08458873
Quinoxalino[2,3-b]phenazine-2,9-disulfonic acid, 5,12-dihydro-, sodium salt (1:2)
Azapentacene
Phacolin
Sodium 5,12-dihydroquinoxalino[2,3-b]phenazine-2,9-disulfonate

Biological Activity

Chemical & Physical Properties

[ Molecular Formula ]:
C18H10N4Na2O6S2

[ Molecular Weight ]:
488.405

[ Exact Mass ]:
487.983704

[ PSA ]:
188.52000

[ LogP ]:
4.27760

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
VD3655000
CAS REGISTRY NUMBER :
3863-80-7
LAST UPDATED :
199712
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C18-H12-N4.2O3-S.2Na
MOLECULAR WEIGHT :
458.38
WISWESSER LINE NOTATION :
T G6 E6 C666 BM FN MM QNJ &.NA..S-O3 2

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>5300 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,328,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1900 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,328,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1190 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,328,1982

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.